Revier Therapeutics
Revier Therapeutics develops small-molecule therapies for cardiometabolic diseases.
$6.95M Seed ·
Source: Health Tech World
Funding history ↓Signals
Website registeredJun 4, 2026 (5 months old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | $6.95M | — | Health Tech World |
Timeline
- Website created
Founders and team
EV
Eva van Rooij FounderMD
Matthias Dewenter FounderMN
Michael Nolan FounderNF
Norbert Frey Founder
Companies like Revier Therapeutics
SStorm Therapeutics$56M Series B+ · Apr 2026
AAlvara TherapeuticsPre Seed · Sep 2026
MMwyngil TherapeuticsSeed · Jun 2026
RRougeTx$58M Series A · Oct 2026
AAlzheon$100M Series B+ · Apr 2022
EEccogene$25.2M Series B+ · Jun 2023
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/revier-therapeutics (get a free API key).